Hims & Hers Health, Inc. (NYSE:HIMS) Director Anja Manuel Buys 4,000 Shares

Hims & Hers Health, Inc. (NYSE:HIMS) Director Anja Manuel bought 4,000 shares of Hims & Hers Health stock in a transaction dated Tuesday, November 12th. The stock was acquired at an average price of $26.94 per share, with a total value of $107,760.00. Following the purchase, the director now directly owns 4,000 shares of the company’s stock, valued at approximately $107,760. This represents a ∞ increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is available through the SEC website.

Anja Manuel also recently made the following trade(s):

• On Thursday, November 14th, Anja Manuel acquired 1,000 shares of Hims & Hers Health stock. The shares were bought at an average cost of $24.50 per share, for a total transaction of $24,500.00.

Hims & Hers Health Trading Down 7.3 %

NYSE HIMS opened at $19.32 on Friday. Hims & Hers Health, Inc. has a 12 month low of $7.40 and a 12 month high of $30.44. The stock has a market cap of $4.15 billion, a PE ratio of 43.91 and a beta of 1.06. The stock’s 50 day moving average is $19.76 and its 200 day moving average is $18.87.

Hims & Hers Health (NYSE:HIMS) last issued its quarterly earnings data on Monday, November 4th. The company reported $0.32 earnings per share for the quarter, beating analysts’ consensus estimates of $0.06 by $0.26. Hims & Hers Health had a return on equity of 10.97% and a net margin of 8.19%. The firm had revenue of $401.56 million during the quarter, compared to analyst estimates of $382.20 million. During the same quarter last year, the business posted ($0.04) earnings per share. The business’s quarterly revenue was up 77.1% compared to the same quarter last year. On average, analysts forecast that Hims & Hers Health, Inc. will post 0.29 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several research analysts have commented on HIMS shares. Canaccord Genuity Group raised their price target on shares of Hims & Hers Health from $24.00 to $28.00 and gave the company a “buy” rating in a report on Tuesday, November 5th. Needham & Company LLC started coverage on Hims & Hers Health in a research report on Thursday, August 22nd. They issued a “buy” rating and a $24.00 price objective on the stock. Imperial Capital cut Hims & Hers Health from an “outperform” rating to an “in-line” rating in a research report on Friday, August 9th. Deutsche Bank Aktiengesellschaft raised their price target on Hims & Hers Health from $23.00 to $27.00 and gave the company a “hold” rating in a report on Wednesday, November 6th. Finally, Piper Sandler reiterated a “neutral” rating and set a $21.00 price target (up previously from $18.00) on shares of Hims & Hers Health in a research report on Tuesday, November 5th. One analyst has rated the stock with a sell rating, eight have given a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $20.71.

Hedge Funds Weigh In On Hims & Hers Health

A number of institutional investors and hedge funds have recently modified their holdings of HIMS. Quest Partners LLC raised its stake in shares of Hims & Hers Health by 22.6% in the third quarter. Quest Partners LLC now owns 4,373 shares of the company’s stock valued at $81,000 after acquiring an additional 807 shares during the period. CWM LLC grew its holdings in Hims & Hers Health by 21.4% during the 3rd quarter. CWM LLC now owns 5,982 shares of the company’s stock valued at $110,000 after purchasing an additional 1,054 shares during the last quarter. Arizona State Retirement System grew its holdings in Hims & Hers Health by 3.0% during the 2nd quarter. Arizona State Retirement System now owns 40,344 shares of the company’s stock valued at $815,000 after purchasing an additional 1,173 shares during the last quarter. Victory Capital Management Inc. lifted its stake in Hims & Hers Health by 6.6% in the second quarter. Victory Capital Management Inc. now owns 19,469 shares of the company’s stock worth $393,000 after purchasing an additional 1,212 shares during the last quarter. Finally, Nisa Investment Advisors LLC boosted its position in shares of Hims & Hers Health by 679.2% during the second quarter. Nisa Investment Advisors LLC now owns 1,839 shares of the company’s stock valued at $37,000 after buying an additional 1,603 shares during the period. Hedge funds and other institutional investors own 63.52% of the company’s stock.

About Hims & Hers Health

Hims & Hers Health, Inc operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers.